Loading...

Almirall, S.A.

LBTSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$15.35
$-0.12(-0.78%)
U.S. Market opens in 14h 23m

Almirall, S.A. (LBTSF) Stock Overview

Explore Almirall, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.3B
P/E Ratio47.58
EPS (TTM)$0.26
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$15.36
3 Months$16.52
1 Year Target$17.48

LBTSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Almirall, S.A. (LBTSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 47.58 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
14.90%
6-Month Change
14.90%
Year-to-Date (YTD) Change
-0.78%
1-Year Change
70.37%
3-Year Change
58.57%
5-Year Change
9.64%
All-Time (Max) Change
71.13%

Contact Information

https://www.almirall.com
34 93 291 30 00
Ronda Del General Miter, 151, Barcelona, NaN, 08022

Company Facts

20,260 Employees
IPO DateAug 3, 2012
CountryES

Frequently Asked Questions